Attorney General Dana Nessel’s ability to go after a major producer of insulin for price gouging was before the Michigan ...
The Michigan Supreme Court will decide whether to overturn past precedent to clear the way for an attorney general probe into ...
10hon MSN
In insulin-pricing case, Nessel asks Michigan Supreme Court to overturn decades of precedent
Michigan Attorney General Dana Nessel contends that the state’s Supreme Court tore a huge loophole in the middle of the ...
Michigan Attorney General Dana Nessel's office is asking the court to overturn two previous rulings and allow an investigation into Eli Lilly and Co.
Stocktwits on MSN
MannKind Stock Soared 8% Today: Why A Surge In Afrezza Inhaled Insulin Sales Matters
Afrezza revenue rose 23% to $18.49 million in the three months through the end of September, owing to higher prices and ...
Analysts anticipate Insulet to report an earnings per share (EPS) of $1.14. The market awaits Insulet's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for ...
Both medications have similar side effects, such as stomach issues like diarrhea, nausea, and bloating. However, metformin’s ...
Trump administration negotiating with Novo Nordisk and Eli Lilly to lower Wegovy, Zepbound prices to $149/month, with some Medicare coverage.
The office of Michigan’s attorney general on Wednesday again urged the state Supreme Court to overturn two prior rulings that it says hamstring its desire to investigate Eli Lilly & Co.’s insulin ...
Zacks Investment Research on MSN
Novo Nordisk Q3 Earnings & Revenues Miss, GLP-1 Drugs Face US Hurdles
Novo Nordisk A/S NVO reported third-quarter 2025 earnings of 70 cents per American Depositary Receipt (ADR), which missed the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results